Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Francois H. Gaston who wrote (775)	11/30/1997 8:50:00 AM
From: TradeOfTheDay	Respond to of 1605

Gaston, thank you for such a deeply informative and thorough post! Bev

To: Francois H. Gaston who wrote (775)	11/30/1997 7:50:00 PM
From: john view	Read Replies (2) \| Respond to of 1605

Francois, can you share your T/A data that suggests VASO is still in a down spin. Quite frankly I would have anticpated a bottoming out by now followed by a brief flat line and then an upturn in late Feb./ early March. Does your data suggest a different scenario?

To: Francois H. Gaston who wrote (775)	12/9/1997 11:53:00 AM
From: Cardiomedics	Read Replies (2) \| Respond to of 1605

Your response to Don Walster is a bit misleading and naive when you look at the course of high technology. Number one: the heart association meeting in 1996 is ancient history even the Vasomedical users who visited the Cardiomedics booth this year were impressed and wanted to do research with the system they saw. The augmentation levels that are now achieved rival those of an intra-aortic balloon pump. Number two: Vasomedical does not own the concept of external counterpulsation and your readers need to be aware that many researchers in the 60's, 70's, and 80's have had major contributions to the present position of counterpulsationin in the market today. Many of these researchers have used lineage of the Cardiomedics system. Cardiomedics recieved its 510K in 1987, Vasomedical recieved theirs in 1995 on substantial equivelancy. Which came first the chicken or the egg. Third: What investors need to remember is the General Motors experience when the Japanees came to town in the 1960's. G.M.made a tactical marketing error. The Japaneese didnt have to re-prove the need or function of the automobile however G.M. thought they owned the market. If we build it they will buy it from us was the overwhelming theme. What stock would you like to have invested in back then. Finally, If anyone considers investing in a technology they should go deeper and look at the technology platform that the product is built upon. Cardiomedics controlls all phases of their technology with Silicone Valley support. All parts are controlled and manufactured by U.S. firms and not subject to any foreign controll. If you look at the evolution that Intra-aortic balloon pumps took you will see a parallel experience closer to home. If you have any questions please write back.

To: Francois H. Gaston who wrote (775)	12/10/1997 9:19:00 AM
From: Jack Ucci	Read Replies (1) \| Respond to of 1605

Perhaps more information on Cardiomedics would be useful and timely for readers of this thread. When is Cardiomedics supposed to go IPO? I seem to recall some mention of January 98. Can anyone firm this up? And who is the underwriter, if such an IPO is in the works? And most importantly what ST impact on VASO's stock price will such an IPO have? Anyone care to comment? Despite the drop since VASO's conference announcement, I sense a little more strength in its stock movement and the strong possibility that it could move up quickly with the announcement of some positive news. It is handling large volume reasonably well. Jack